📰 Clinical Update News

Clinical Update News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Update. Real-time updates on events, politics, business and more.

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints

May 20, 2024

- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - - DYNE-101 Showed Improvement in Myotonia,...

United States Stacy Nartker Wildon Farwell Amy Reilly John Cox Exchange Commission

Source: marketscreener.com

Dyne Therapeutics Announces New Clinical Data from ACHIEVE

May 20, 2024

- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months - ...

United States Amy Reilly John Cox Stacy Nartker Wildon Farwell Exchange Commission

Source: globenewswire.com

Destigmatizing Personality Disorders

May 3, 2024

Don't miss these 2 APA Annual Meeting sessions on personality disorders!

United States American Psychiatric Association Annual Meeting Javits Center Psychiatric Association Annual Meeting Clinical Update Personality Disorders

Source: psychiatrictimes.com

Biomea Fusion Presents Long-Term Follow-Up Data Showing Improved Glycemic Control after 22 Weeks Off Treatment in Ongoing Phase II Study (COVALENT-111) of BMF-219 in Adults with Type 2 Diabetes in a Poster Presentation at the World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

December 8, 2023

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes At Week 26, 22 weeks after the last dose of BMF-219,...

United States Exchange Commission Securities Exchange Clinical Update Multiple Ascending Dose Glycemic Data

Source: marketscreener.com

MIMS Learning Clinical Update podcast explores the 'defining issue of our age'

September 25, 2023

The latest episode of the MIMS Learning Clinical Update podcast features an interview with climate change activist and former BMJ editor Dr Richard Smith.

City Of United Kingdom Richard Smith United Kingdom Health Alliance On Climate United Kingdom Health Alliance Climate Change

Source: gponline.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Breaking barriers in healthcare - the event you can't afford to miss

May 3, 2023

MIMS Learning editor Pat Anderson talks to GPonline about the forthcoming MIMS Learning Live event on 9 June 2023 at the Business Design Centre, London.

United Kingdom City Of Suchitra Chinthapalli Louise Newson Matt Fay Michael Kirby

Source: gponline.com

Learn, earn CPD and network with peers at MIMS Learning Live London

March 29, 2023

Registration is now open for MIMS Learning Live London on 9 June at the Business Design Centre. Registration is FREE. Earn up to 5.25 CPD in this 5-stream event, covering nine clinical topics, helping you meet your learning objectives for appraisal.

City Of United Kingdom Louise Newson Toby Wallace Ravi Ramanathan Tamir Malley

Source: gponline.com

EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer's Disease Conference (CTAD)

November 28, 2022

EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Conference Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat

San Francisco United States Noord Holland Julie Seidel Valeria Fisher Halle Saale

Source: finanznachrichten.de